Literature DB >> 27005781

High levels of circulating extracellular vesicles with altered expression and function during pregnancy.

Fabiola da Silva Nardi1, Tatiana Ferreira Michelon2, Jorge Neumann3, Luis Felipe Santos Manvailer4, Bettina Wagner5, Peter A Horn6, Maria da Graça Bicalho7, Vera Rebmann8.   

Abstract

Extracellular vesicles (EVs) are widely considered important modulators of cell-cell communication and may interact with target cells locally and on a systemic level. Several studies had shown that circulating EVs' levels are increased during pregnancy. However, EVs characteristics, composition and biological functions in pregnancy still need to be clarified. This study aims to determine if circulating EVs during pregnancy are modified regarding levels, markers and cytokine profile as well as their reactivity towards peripheral blood cells. 26 pregnant women (PW) being in the second gestational trimester and 59 non-pregnant women (NPW) were investigated. EVs enrichment was performed by ExoQuick™ or ultracentrifugation; nanoparticle tracking analysis, SDS-PAGE followed by Western Blotting and densitometry, and IFN-γ, IL-10 and TGF-β1 ELISA for EVs characterization; imaging flow cytometry to analyze EVs' uptake by peripheral blood cells and flow cytometry were performed to analyze EVs function regarding induction of caspase-3 activity. Circulating EVs' levels were increased during pregnancy [26.9×10(6)EVs/ml (range: 6.4-46.3); p=0.003] vs NPW [18.9×10(6)EVs/ml (range: 2.5-61.3)]. Importantly, the immunosuppressive TGF-β1 and IL-10 cytokine cargo were increased in EVs of PW even after normalization to 1 million EVs [TGF-β1: 0.25pg/10(6)EVs (range: 0.0-2.0); p<0.0001] and [IL-10: 0.21pg/10(6)EVs (range: 0.0-16.8); p=0.006] vs NPW. Although EVs derived from non-pregnant and pregnant women were taken up by NK cells, the latter exclusively enhanced the caspase-3 activity in CD56(dim) NK cells (8.2±0.9; p=0.02). The qualitative and quantitative pregnancy-related alterations of circulating EVs provide first hints for an immune modulating role of circulating EVs during pregnancy.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Caspase-3 activity; Extracellular vesicles; IL-10; NK cells; Pregnancy; TGFβ-1

Mesh:

Substances:

Year:  2016        PMID: 27005781     DOI: 10.1016/j.imbio.2016.03.001

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  8 in total

Review 1.  Extracellular vesicles and their immunomodulatory functions in pregnancy.

Authors:  Soumyalekshmi Nair; Carlos Salomon
Journal:  Semin Immunopathol       Date:  2018-04-03       Impact factor: 9.623

Review 2.  Extracellular vesicles and immune response during pregnancy: A balancing act.

Authors:  Adrian E Morelli; Yoel Sadovsky
Journal:  Immunol Rev       Date:  2022-02-23       Impact factor: 10.983

Review 3.  The promise of placental extracellular vesicles: models and challenges for diagnosing placental dysfunction in utero†.

Authors:  Lindsey N Block; Brittany D Bowman; Jenna Kropp Schmidt; Logan T Keding; Aleksandar K Stanic; Thaddeus G Golos
Journal:  Biol Reprod       Date:  2021-01-04       Impact factor: 4.161

Review 4.  Roles of MicroRNA across Prenatal and Postnatal Periods.

Authors:  Ilaria Floris; Jamie D Kraft; Illimar Altosaar
Journal:  Int J Mol Sci       Date:  2016-11-28       Impact factor: 5.923

Review 5.  Circulating MicroRNAs as Biomarkers of Gestational Diabetes Mellitus: Updates and Perspectives.

Authors:  Elisa Guarino; Chiara Delli Poggi; Giuseppina Emanuela Grieco; Valeria Cenci; Elena Ceccarelli; Isabella Crisci; Guido Sebastiani; Francesco Dotta
Journal:  Int J Endocrinol       Date:  2018-04-12       Impact factor: 3.257

Review 6.  Multiomic immune clockworks of pregnancy.

Authors:  Laura S Peterson; Ina A Stelzer; Amy S Tsai; Mohammad S Ghaemi; Xiaoyuan Han; Kazuo Ando; Virginia D Winn; Nadine R Martinez; Kevin Contrepois; Mira N Moufarrej; Stephen Quake; David A Relman; Michael P Snyder; Gary M Shaw; David K Stevenson; Ronald J Wong; Petra Arck; Martin S Angst; Nima Aghaeepour; Brice Gaudilliere
Journal:  Semin Immunopathol       Date:  2020-02-04       Impact factor: 9.623

Review 7.  MiRNAs in Gestational Diabetes Mellitus: Potential Mechanisms and Clinical Applications.

Authors:  Zhao-Nan Liu; Ying Jiang; Xuan-Qi Liu; Meng-Meng Yang; Cheng Chen; Bai-Hui Zhao; He-Feng Huang; Qiong Luo
Journal:  J Diabetes Res       Date:  2021-11-24       Impact factor: 4.011

Review 8.  MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus.

Authors:  Xiyao Yang; Na Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-03       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.